Literature DB >> 16304573

Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials.

H Armendariz, M A Fernandez Barbieri, D Freigeiro, F Lastiri, M S Felice, E Dibar.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16304573     DOI： 10.1038/sj.leu.2403854

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

Review 1.  Biology, risk stratification, and therapy of pediatric acute leukemias: an update.

Authors:  Ching-Hon Pui; William L Carroll; Soheil Meshinchi; Robert J Arceci
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

2.  Survival of Mexican children with acute myeloid leukaemia who received early intensification chemotherapy and an autologous transplant.

Authors:  Elva Jiménez-Hernández; María Teresa Dueñas-González; José Arellano-Galindo; María Elena Medrano-Ortíz-De-Zárate; Vilma Carolina Bekker-Méndez; Adolfina Berges-García; Karina Solís-Labastida; Berenice Sánchez-Jara; Héctor Manuel Tiznado-García; Ethel Zulie Jaimes-Reyes; Xochiketzalli García-Jiménez; Laura Espinoza-Hernández; Nora Nancy Núñez-Villegas; Sergio Franco-Ornelas; Ruy Xavier Pérez-Casillas; Octavio Martínez Villegas; Teresa Marin Palomares; Juan Manuel Mejía-Aranguré
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

3.  High level of miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcome.

Authors:  Lihua Xu; Yang Guo; Wenying Yan; Jiannong Cen; Yuna Niu; Qing Yan; Hailong He; Chien-Shing Chen; Shaoyan Hu
Journal:  EXCLI J       Date:  2017-03-07       Impact factor: 4.068
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.